The scale of the problem gives the findings urgency. Chronic kidney disease is defined by structural or functional abnormalities of the kidneys lasting more than three months, or by a decline in the glomerular filtration rate below 60 mL/min/1.73 m². Under the international KDIGO 2012 guidelines, the disease is staged from G1 to G5 by filtration rate and further risk-stratified by albuminuria, with the most advanced cases—those with a filtration rate below 20—requiring renal replacement therapy. Mortality is projected to rise by more than 30 percent between 2022 and 2050, and in Spain, where the review team is based, an estimated one in seven adults lives with the disease, a figure comparable to the United States. Diabetes, hypertension, obesity, cardiovascular disease and age over 60 are the principal risk factors, and lower socioeconomic status compounds the risk.

Quality of life, and specifically health-related quality of life, is the outcome that matters most to patients, yet it is consistently depressed in this population. Compared with healthy individuals, people with chronic kidney disease report reduced physical activity, impaired sexual function, diminished occupational capacity and worse general health, effects that deepen with age and comorbidities. The review’s authors asked a deceptively simple question using the PICO framework: in adults with chronic kidney disease, does health education increase quality of life compared with no education? To answer it, they searched PubMed, the Virtual Health Library and EBSCOhost for studies published between 2014 and 2024, screening 940 records and, after applying inclusion and exclusion criteria, retaining twelve studies for the final synthesis.

The twelve studies fell into four intervention categories that the authors describe as intermediate mechanisms linking education to quality of life: nutrition and fluid management, physical activity, self-management and disease knowledge, and emotional intelligence. Nine were randomized controlled trials, two were quasi-experimental, and one was a single-arm pre-post study. The nutritional trials were among the most revealing. In a randomized trial of 87 hemodialysis patients, individualized dietary advice significantly reduced sodium intake from 90 days onward, along with consumption of packaged seasonings, processed meat and instant noodles, although quality of life itself did not change significantly between groups. Another trial delivered nutrition education virtually, through a Telegram messaging channel, and found that patients not only improved their quality of life but also lowered their serum potassium, sodium, phosphorus and magnesium levels.

The physical activity studies added a striking technological dimension. In the Kidney BEAM trial, 268 patients in the United Kingdom were randomized to a twelve-week digital renal rehabilitation program with live and pre-recorded exercise sessions, or to standard care. The digital group showed significant gains in the mental component of quality of life, patient activation, social function, energy and sit-to-stand performance, and a reduction in the perceived burden of kidney disease—yet the physical component score itself did not change significantly. A Chinese trial of home-based aerobic exercise, by contrast, improved both physical and mental quality of life domains, along with walking capacity, sit-to-stand performance, exercise self-efficacy and anxiety scores. The contrast suggests that intensity and individualization, not the delivery medium, may determine whether physical benefits follow.

Perhaps the most consistent pattern across the synthesis was the divergence between mental and physical improvement. In several studies measuring both components separately—including the digital rehabilitation trial, the self-management program and the peritoneal dialysis retraining study—the mental component of quality of life improved more reliably and to a greater degree than the physical component. The exceptions were instructive: the three studies that found significant gains in both domains combined structured physical activity or nutritional components with individualized, higher-intensity delivery. The authors propose that this differential pattern, rarely addressed explicitly in earlier reviews, reflects the nature of the interventions themselves rather than unexplained inconsistency in the evidence.

Self-management and emotional intelligence programs produced some of the most encouraging results. A twelve-week Australian intervention grounded in social-cognitive theory, combining face-to-face sessions, motivational interviewing and telephone follow-up, improved self-efficacy, disease knowledge, fruit and vegetable consumption and communication with healthcare providers, while reducing alcohol intake, blood pressure and depression and stress scores. In hemodialysis patients, an emotional intelligence program built around self-awareness, self-control, empathy, self-motivation and social skills raised all five domains significantly and improved quality of life at six and twelve weeks. A Bangladeshi trial combining an awareness campaign with mobile health technologies, leaflets and weekly home visits increased disease knowledge and improved blood pressure, body mass index and dietary salinity—though, notably, quality of life measured with the generic EQ-5D-5L instrument showed no significant effect in any analysis.

That last finding points to one of the review’s most practical insights: the choice of measurement instrument matters enormously. In the Kidney BEAM trial, the same patients showed significant improvement on the disease-specific KDQoL-SF questionnaire but not on the generic EQ-5D-5L, suggesting that generic instruments may be less sensitive to change in this population. The authors argue that future trials should adopt validated, kidney-specific quality-of-life measures to avoid false negatives. They also flag findings that did not reach significance rather than burying them: the sodium-restriction trial found no between-group quality-of-life difference, and one Saudi study even reported that the control group scored better on the pain domain of the SF-36, a counter-intuitive result the original publication had not discussed.

The review is candid about the weakness of its evidence base. Applying the Cochrane RoB2 and ROBINS-I tools, the authors rated most studies as having some concerns or high risk of bias, and a simplified GRADE assessment judged the certainty of evidence for the mental component of quality of life to be low and for the physical component very low. Heterogeneity was substantial: six different quality-of-life instruments were used across studies of hemodialysis, peritoneal dialysis and non-dialysis patients, making statistical pooling inappropriate. The review itself was not prospectively registered, was limited to free full-text English and Spanish publications, and could not formally assess publication bias, although the predominance of positive findings raises that possibility. The authors conclude that the results should be interpreted as suggestive rather than conclusive.

Even with those caveats, the direction of the evidence is hard to ignore. Educational interventions were associated with improvements in blood pressure, serum electrolytes, physical function, depression and anxiety in most studies, and patients who received education consistently fared better than those on standard care. The interventions were delivered through remarkably varied channels—Telegram channels, digital rehabilitation platforms, telephone reminders, home visits and bedside counseling—demonstrating that health education can be scaled flexibly and cheaply. The authors note that more frequent and intense interventions produced greater effects, that multidisciplinary teams involving nurses and other professionals could optimize outcomes, and that better-educated patients make more informed decisions about renal replacement therapy. Given that chronic kidney disease already consumes enormous healthcare resources and that its clinical and economic burden is projected to grow through 2027, teaching patients to understand and manage their own disease may prove one of the highest-yield investments available—provided that larger, prospectively registered trials with consistent instrumentation can confirm what these twelve studies only suggest.

Subject of Research: The impact of health education interventions on quality of life in patients with chronic kidney disease

Article Title: Impact of health education on quality of life in patients with chronic kidney disease

Article References: Vicente-Garrido, C., Vicente García, T., Sánchez Aguadero, N., González Sánchez, J., Alonso Domínguez, R., Recio Rodríguez, J. I., Bermejo Gil, B., Coello González, E., & Sánchez-Tocino, M. L. (2026). Impact of health education on quality of life in patients with chronic kidney disease. iScience, 29(10), Article 117555. https://doi.org/10.1016/j.isci.2026.117555

Image Credits: AI Generated

DOI: 10.1016/j.isci.2026.117555

Keywords: chronic kidney disease, health education, quality of life, systematic review, hemodialysis, patient self-management, nutrition education, physical activity, digital health, emotional intelligence, renal replacement therapy, GRADE certainty